Pembrolizumab treatment of a patient with xeroderma pigmentosum with disseminated melanoma and multiple nonmelanoma skin cancers

Br J Dermatol. 2018 May;178(5):1009. doi: 10.1111/bjd.16525.
No abstract available

Publication types

  • Research Support, N.I.H., Intramural
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Cell Death
  • Humans
  • Immunotherapy
  • Melanoma*
  • Skin Neoplasms*
  • Xeroderma Pigmentosum*

Substances

  • Antibodies, Monoclonal, Humanized
  • pembrolizumab